Femme Homme
- | Pays :
- Thailand
- Estonia
- Dominican Republic
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to evaluate safety and immunogenicity of GSK Biologicals' meningococcal vaccine GSK134612 (MenACWY-TT) co-administered with Cervarix as compared to MenACWY-TT and Cervarix administered alone and the co-administration of MenACWY-TT with Cervarix and Boostrix as compared to MenACWY-TT administered alone and Cervarix co-administered with Boostrix.
Critère d'inclusion
- Infections, Meningococcal